Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: Results of a 6-week, randomized, double-blind, crossover trial

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)


Background: Uremic toxicity is a major concern in the dialysis population. There is keen interest in techniques that increase the removal of larger uremic molecules. We examined the short-term impact of a new, more porous, super-flux Helixone membrane (FX-E) versus the conventional high-flux Helixone
Original languageEnglish
Pages (from-to)93 - 101
Number of pages9
JournalAmerican Journal of Kidney Diseases
Issue number1
Publication statusPublished - 2008

Cite this